These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31407271)

  • 61. n-pentyl N-acetylprolinate. A new skin penetration enhancer.
    Harris WT; Tenjarla SN; Holbrook JM; Smith J; Mead C; Entrekin J
    J Pharm Sci; 1995 May; 84(5):640-2. PubMed ID: 7658358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum.
    Singh BN; Singh RB; Singh J
    Int J Pharm; 2005 Jul; 298(1):98-107. PubMed ID: 15913928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis.
    Choi EH; Lee SH; Ahn SK; Hwang SM
    Skin Pharmacol Appl Skin Physiol; 1999; 12(6):326-35. PubMed ID: 10545829
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique.
    Goodman M; Barry BW
    J Invest Dermatol; 1988 Oct; 91(4):323-7. PubMed ID: 3171212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Augmentation of transdermal drug penetration].
    Préat MV
    Bull Mem Acad R Med Belg; 1998; 153(5-6):295-300; discussion 301-2. PubMed ID: 9988935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of ion-pairing and enhancers on scutellarin skin permeability.
    Wang M; Fang L; Ren C; Li T
    J Pharm Pharmacol; 2008 Apr; 60(4):429-35. PubMed ID: 18380914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Utility of topical formulations of morphine hydrochloride containing azone and N-methyl-2-pyrrolidone.
    Sugibayashi K; Sakanoue C; Morimoto Y
    Sel Cancer Ther; 1989; 5(3):119-28. PubMed ID: 2814004
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preparation and evaluation of 5, 9-dimethyl-2-cyclopropyl-2-decanol as a penetration enhancer for drugs through rat skin.
    Khan GM; Hussain A; Hanif RM
    Pak J Pharm Sci; 2011 Oct; 24(4):451-7. PubMed ID: 21959804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Passive and iontophoretic transdermal penetration of chlorpromazine.
    Alvarez-Figueroa MJ; González-Aramundiz JV
    Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Percutaneous absorption and elimination of the penetration enhancer Azone in humans.
    Wiechers JW; Drenth BF; Jonkman JH; de Zeeuw RA
    Pharm Res; 1987 Dec; 4(6):519-23. PubMed ID: 3508567
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synergistic effect of enhancers for transdermal drug delivery.
    Mitragotri S
    Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Influence of different penetration enhancers on Lappaconitine transcutaneous permeation].
    Han M; Zhong YW; Li XP; Wu Z; Liang WQ; Gao JQ
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(11):1252-5. PubMed ID: 18831198
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transdermal iontophoresis and solute penetration across excised human skin.
    Singh P; Anliker M; Smith GA; Zavortink D; Maibach HI
    J Pharm Sci; 1995 Nov; 84(11):1342-6. PubMed ID: 8587053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemical penetration enhancers in stratum corneum - Relation between molecular effects and barrier function.
    Pham QD; Björklund S; Engblom J; Topgaard D; Sparr E
    J Control Release; 2016 Jun; 232():175-87. PubMed ID: 27108613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.
    Puri A; Murnane KS; Blough BE; Banga AK
    Int J Pharm; 2017 Aug; 528(1-2):452-462. PubMed ID: 28633107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combined strategies for enhancing the transdermal absorption of midazolam through human skin.
    Balaguer-Fernández C; Femenía-Font A; Muedra V; Merino V; López-Castellano A
    J Pharm Pharmacol; 2010 Sep; 62(9):1096-102. PubMed ID: 20796187
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanism of skin penetration-enhancing effect by laurocapram.
    Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
    J Pharm Sci; 1992 Jan; 81(1):58-64. PubMed ID: 1619571
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhanced transdermal drug delivery techniques: an extensive review of patents.
    Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An explanation for the variation of the sonophoretic transdermal transport enhancement from drug to drug.
    Mitragotri S; Blankschtein D; Langer R
    J Pharm Sci; 1997 Oct; 86(10):1190-2. PubMed ID: 9344179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.